Vijaya Diagnostic IPO Live Subscription Status

Live subscription status across each investor category and analyst recommendations
Vijaya-Diagnostic-IPO-Subscription

Vijaya Diagnostic IPO Subscription Status: FINAL

Vijaya Diagnostic Center Limited, incorporated in 1981, is the largest integrated diagnostic chain in southern India, by operating revenue, and also one of the fastest-growing diagnostic chains by revenue for the fiscal year 2020.

Investor CategoryQuotaSubscription
Institutional (QIB)50%13.07x
Non-Insti. (HNI)15%1.32x
Retail (RII)35%1.09x
Employee0.98x
Total Subscription100%4.54x

Vijaya Diagnostic IPO Subscription: End of Day Update

DayDay 1Day 2Day 3
QIB 0.23x 0.32x 13.07x
HNI 0.01x 0.05x 1.32x
Retail 0.46x 0.74x 1.09x
Employee0.24x0.52x0.98x
Total 0.30x 0.47x 4.54x
Will be updated at EOD each Day

Vijaya Diagnostic IPO Subscription: Analyst Recommendations

ANGEL BROKING – NEUTRAL

“IPO has been priced at price to earning of 64 times of FY2021 earning which is near around the listed players in India. We have a neutral outlook on Vijaya Diagnostic centre IPO,”

Choice Broking – AVOID [Report]

“At higher price band of Rs. 531, VDCL is demanding a TTM P/E multiple of 47x, which is in-line to the peer average. Thus the issue seems to be fully priced. Thus we assign a “AVOID” rating for the issue.”

KR Choskey – SUBSCRIBE

“At the IPO’s upper price band of Rs 531, Vijaya Diagnostic Centre is being valued at 64.3x earnings, offering a potential upside relative to the industry average of 89x. Considering strong brand recall, integrated model, high share of B2C, customer stickiness and sector leadership in southern India, we recommend a subscribe with a long term perspective for IPO,”

MARWADI FINANCIALS, ARIHANT CAPITAL – SUBSCRIBE

Vijaya Diagnostic IPO Subscription: Key IPO Details

TypeValue
Issue Size1,895.04
Open Date1/09/2021
Close Date3/09/2021
Face Value₹1/- per Equity Share
IPO Price₹522 – ₹531
Lot Size28 shares
LotsMin 1 – Max 13

Vijaya Diagnostic IPO Subscription: Financials

201920202021 Mar2021 June
Revenue from Ops₹292.59 Cr₹332.82 Cr₹376.75 Cr₹122.67 Cr
Profit before Excep*₹65.32 Cr₹83.43 Cr₹112.12 Cr₹44.21 Cr
Profit after Tax46.27 Cr₹62.51 Cr₹84.91 Cr₹33.92 Cr
EPS (Basic)4.506.138.263.23
*Tax and Exceptional Items
As of March 2020EPS (Avg*)P/E (Floor)P/E (Cap)
Based on basic EPS6.9275.4376.73
* Weighted Average for last 3 years

Vijaya Diagnostic IPO: Comparison with listed industry peers

CompanyP/E (Cap)
Vijaya Diagnostic76.73
Highest (Dr. Lal Path Labs)107.3
Lowest (Metropolis Healthcare)74.4

Vijaya Diagnostic IPO Subscription – FAQs

1. How to apply for Vijaya Diagnostic IPO in the Retail Category?

A: An investor in the retail category may either apply through the UPI process via DEMAT account or the ASBA process via bank account

2. How to apply for Vijaya Diagnostic IPO in HNI Category?

A: An investor can apply in the HNI category only through the ASBA process via bank account

3. Where can I find the Red Herring Prospectus (RHP) details?

A: You can visit the NSE or SEBI website for these details. Alternately you can click here: RHP

Leave a Reply

9 − three =

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.